Riskpilot← Back to searchSign inGet full accessSEM APOTEK AS
ASActiveOrg 924298340Semsbyveien 81, 3170 SemRetail sale of pharmaceutical products · NACE 4773Est. 20190 employees
Revenue 2023
NOK 29,9M
+19% vs 2022
EBITDA margin
9.2%
+31% vs 2022
Equity ratio
24.6%
Financial strength
Net profit 2023
NOK 2,1M
+35% vs 2022
| Revenue | NOK 29,9M | +19% |
| EBITDA | NOK 2,8M | +31% |
| Net profit | NOK 2,1M | +35% |
| Total assets | NOK 10,6M | +34% |
| Equity | NOK 2,6M | +462% |
| Employees | 0 | — |
Legal name
SEM APOTEK AS
Org number
924298340
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
23. desember 2019
Share capital
NOK 452 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Semsbyveien 81, 3170 Sem
Phone
+4733355710
Email
post@semsbyenapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 12 387 | 20 720 | 25 133 | 29 871 |
| Staff expenses | −0 | −2 197 | −3 135 | −3 694 | −4 142 |
| EBITDA | −46 | 970 | 1 834 | 2 110 | 2 763 |
| Depreciation & amort. | −0 | −86 | −125 | −125 | −125 |
| EBIT | −46 | 883 | 1 710 | 1 986 | 2 638 |
| Net financials | 0 | −14 | 2 | 51 | 118 |
| Profit before tax | −46 | 870 | 1 712 | 2 036 | 2 756 |
| Tax | −0 | 180 | 377 | 448 | 607 |
| Net profit | −46 | 690 | 1 335 | 1 588 | 2 149 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 162 | 6 447 | 5 982 | 7 960 | 10 630 |
| Equity | 110 | 502 | 477 | 466 | 2 615 |
| Long-term debt | 0 | 649 | 509 | 14 | 6 |
| Short-term debt | 52 | 5 295 | 4 996 | 7 480 | 8 010 |
| Total debt | 52 | 5 945 | 5 505 | 7 494 | 8 016 |
EBITDA margin
9.2%
This company
15.8%
Market median
-42% vs market
20192023
Equity ratio
24.6%
This company
38.2%
Market median
-36% vs market
20192023
Return on equity
82.2%
This company
18.4%
Market median
+347% vs market
20192023
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20192023
Asset turnover
2.81×
This company
1.12×
Market median
+151% vs market
20192023
Debt / equity
3.07×
This company
0.62×
Market median
-395% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-11-17 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VH Contact Person | Contact Person | 2024 | — | — |
ES Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Apotekservice As | Company | 25.0% | 25.0% | 2023 |
Fraunar As | Company | 25.0% | 25.0% | 2023 |
Tr-H As | Company | 25.0% | 25.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fraunar As
SEM APOTEK AS Board members of SEM APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vegard Hoff | Contact Person | 0 companies |
| Ewelina Storesund | Chief Executive Officer | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Kurt Leon Haga | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |